After Eli Lilly and Co (NYSE: LLY) earlier announce the failure of its Alzeheimer’s candidate solanezumab, the entire Alzheimer's sector could feel the aftershocks. While some of the players have since recovered from early morning drops, a few are still in the red in early Wednesday afternoon.
Alzheimer's Treatment Stocks
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Below are the players within the sector, and their subsequent stock movements at time of writing:
- AC Immune Ltd (NASDAQ: ACIU): Down 16.06 percent at $11.50.
- Alkermes Plc (NASDAQ: ALKS): Up 0.69 percent at $58.74.
- Anavex Life Sciences Corp. (NASDAQ: AVXL): Up 6.76 percent at $3.63.
- Biogen Inc (NASDAQ: BIIB): Down 3.94 percent at $305.59.
- Eli Lilly and Co: Down 10.76 percent at $67.82.
- Neuralstem, Inc. (NASDAQ: CUR): Up 3.81 percent at $0.270.
- Novartis AG (ADR) (NYSE: NVS): Up 0.98 percent at $68.76.
- Roche Holding Ltd. (ADR) (OTC: RHHBY): Down 1.3 percent at $27.40.